The treatment of mice with the RS504393 preserved the expression of LYVE-1 protein on cardiac endothelial cells (Fig. 7H, supplementary Figure 7B) along with a significant reduction of cardiac MMP12 expression after 1 week of TAC (Fig. 7I). Here, LYVE1 is linked to persistent truncus arteriosus.